Capabilities

EN | FR | NL | ES

Capabilities

The capability layer for almost every biological program.

CDMO Network Europe maps sponsor programs to development, manufacturing, analytical, regulatory, and supply capabilities across the European ecosystem.

We are not limited to one facility, one modality, or one platform. The network model allows broad routing across biologics, advanced therapies, microbial systems, diagnostics, animal health, food biotech, industrial biology, exosomes, LNPs, AAV, and emerging hybrid platforms.

Discovery to GMP.

Early research, process development, clinical supply, commercial manufacturing, and transfer.

Classic to exotic.

mAbs, proteins, enzymes, AAV, LNP, exosomes, phage, microbiome, diagnostics, animal health.

Capability, not claims.

We route by real technical fit: host, scale, quality level, analytics, format, and timeline.

Pan-European reach.

One route can involve multiple specialized partners across development and supply stages.

Core Capability Domains

From idea to controlled biological supply.

CDMO Network Europe organizes capabilities by the work a program actually needs: discovery, engineering, process development, manufacturing, analytics, quality, transfer, and supply.

◇

Discovery & Early Research

For early feasibility, material generation, assay setup, and platform exploration.

  • Construct design and expression screening
  • Research-grade proteins, antibodies, enzymes, reagents
  • Assay development, antigen prep, feasibility batches
⌬

Cell Line & Strain Engineering

For programs requiring host selection, expression engineering, cloning, banking, and productivity improvement.

  • CHO, HEK, E. coli, yeast, Pichia, Bacillus, insect
  • MCB/WCB, GMP banking, cell line characterization
  • Microbial strain optimization and recombinant expression
△

Process Development

For manufacturability, scale-up, purification, robustness, and yield improvement.

  • Upstream, downstream, DoE, media/feed, purification
  • Scale-down models, process characterization
  • Fermentation, mammalian culture, viral platforms
◎

Drug Substance Manufacturing

For non-GMP, GMP, clinical, and commercial biological active production.

  • Microbial, mammalian, yeast, insect, viral, plasmid
  • Proteins, mAbs, enzymes, pDNA, vectors, vaccines
  • Batch production, tech transfer, scale-up, redundancy
▣

Drug Product & Fill-Finish

For final formulation, sterile formats, clinical packaging, and controlled supply.

  • Aseptic fill, vials, syringes, cartridges, lyophilization
  • LNP fill, viral vector fill, biologics DP
  • Clinical supply, labeling, packaging, release support
⌕

Analytical Development & QC

For identity, purity, potency, safety, release, characterization, and comparability.

  • HCP, residual DNA, endotoxin, sterility, mycoplasma
  • Potency, ELISA, qPCR, ddPCR, LC-MS, HPLC, CE
  • Method development, transfer, validation, stability
◌

Formulation & Stability

For product presentation, shelf-life, excipient strategy, and final format selection.

  • Buffer screening, excipients, freeze-thaw, forced degradation
  • Lyophilization development and cake characterization
  • Container closure, leachables/extractables, storage
□

Regulatory, Quality & Compliance

For GMP readiness, documentation, auditability, comparability, and CMC support.

  • QMS, batch records, deviations, CAPA, audit support
  • CMC documentation, EU/UK pathways, release strategy
  • Quality agreements, supplier qualification, compliance review
⟲

Tech Transfer & Scale-Up

For preserving technical intent as programs move between sites, stages, or partners.

  • Transfer packages, analytical transfer, comparability
  • Facility-fit review, equipment mapping, risk assessment
  • Clinical-to-commercial and site-to-site transition
✦

Supply Chain & Logistics

For controlled movement, storage, packaging, sourcing, and continuity across Europe.

  • Cold chain, frozen, ambient, controlled shipping
  • Raw material sourcing, chain of custody, clinical supply
  • Import/export, regional routing, storage, distribution
◈

Digital Infrastructure & Routing

For structured intake, capability mapping, partner filtering, and routing intelligence.

  • Program intake, RFQ structure, decision logic
  • Capability matrix, modality-stage-fit mapping
  • Partner qualification, workflow visibility, data continuity
⚕

Specialized & Edge Programs

For unusual platforms that do not fit standard biologics outsourcing categories.

  • Exosomes, extracellular vesicles, phage, microbiome
  • Animal health, food biotech, industrial biology
  • Hybrid biologic-device, diagnostics, nanomedicine

Network Coverage

Built to cover the long tail of biological manufacturing.

The value of a network is breadth plus structure. CDMO Network Europe can support mainstream biologics and the obscure, difficult, hybrid, niche, emerging, or regional programs that do not route cleanly through a single CDMO category.

Biologics, proteins & engineered binders

mAbsbispecific antibodiestrispecific antibodiesFab fragmentsFc-fusionsnanobodiesVHHscFvantibody fragmentsrecombinant proteinscomplex biologicsenzymesgrowth factorscytokineshormonesalbumin fusionscollagengelatincaseinwhey proteinspeptidesprotein conjugatesPEGylated proteinsfusion proteinsFc-engineered proteinsantigensreagentsdiagnostic proteins

Genetic medicines, nucleic acids & delivery

mRNAself-amplifying RNAcircular RNAsiRNAmiRNAantisense oligosplasmid DNAminicircle DNAlinear DNAgene editing payloadsCRISPRCas9base editingprime editingLNPspolymeric nanoparticlesliposomesnanocarriersRNA formulationnucleic acid analyticsencapsulationsterile fillpotency assays

Viral vectors, vaccines & infectious disease platforms

AAVlentiviral vectorsadenovirusretroviral vectorsHSV vectorsbaculovirusVLPsviral vaccinessubunit vaccinesrecombinant vaccinesmRNA vaccinesDNA vaccinesconjugate vaccinesprotein antigensadjuvantsviral clearanceBSL-2 programscell-based vaccinespandemic preparednessclinical vaccine supplyaseptic fill

Cell therapy, regenerative medicine & tissue platforms

autologous cell therapyallogeneic cell therapyCAR-TTCR-TNK cellsmacrophage therapystem cellsiPSCMSCcell bankingviral transductionnon-viral editingclosed processingcryopreservationpotency assaysrelease testingtissue engineeringorganoidsregenerative medicine

Microbial, yeast, fermentation & live biology

E. coliBacillusLactococcusLactobacillusBifidobacteriumClostridiaanaerobesPichiaSaccharomycesYarrowiaKomagataellaStreptomycesfilamentous fungiprecision fermentationfed-batchcontinuous fermentationsolid-state fermentationspray dryinglyophilizationlive biotherapeuticsprobioticssynbioticsmicrobiomestrain bankingGMP MCB/WCB

Exosomes, extracellular vesicles & advanced particles

exosomesextracellular vesiclesEV characterizationCD9CD63CD81TSG101NTAparticle sizingcargo analysisEV potencyMSC-derived EVsengineered vesiclesliposomespolymeric particlesnanoparticlesvirus-like particlesdrug delivery particlesnanomedicinesterile particle fill

Diagnostics, reagents, research tools & analytical products

IVD reagentsdiagnostic enzymesantibodiesassay antigensELISA kitslateral flow reagentsqPCR componentsNGS reagentscalibratorscontrolscritical raw materialsprotein standardsmultiplex assaysbiomarker assayscompanion diagnosticsresearch-use-only reagentsQC release reagentslife science tools

Animal health, veterinary & agricultural biology

veterinary vaccinesanimal mAbsUSDA-style biologicsfish vaccineslivestock biologicscompanion animal therapeuticsveterinary diagnosticsanimal probioticsfeed enzymesanimal nutritionag biologicalsbiopesticidesbiofertilizersplant growth microbessoil microbiomeag enzymeslivestock microbiome

Food, nutrition, cosmetics & industrial biotechnology

alternative proteinsrecombinant caseinrecombinant wheycollagengelatinfood enzymesprecision-fermented ingredientsflavorssweet proteinsnutraceutical ingredientscosmetic activesindustrial enzymesbiopolymersbiosurfactantsbioplasticsspecialty chemicalsfermented ingredientsGRAS supportfood-grade fermentation

Rare, hybrid, edge-case & emerging programs

oncolytic virusesphage therapybacteriophagesynthetic biologycell-free systemsextract manufacturingprotein scaffoldsaptamersradiolabeled biologicsbiologic-device hybridsimplantable biologicscontrolled-release biologics3D bioprinting inputsmarine biotechalgaefungal biotechnologybiosecurity-sensitive programspublic sector programsnon-standard CMC

Capability routing is a decision system, not a vendor list.

A program is matched by modality, stage, host system, quality level, geography, analytical burden, final format, timeline, and commercial path. That is why CDMO Network Europe functions as a coordination layer, not a static directory.

Product type Biologic, vaccine, gene therapy, cell therapy, enzyme, diagnostic reagent, LBP, exosome, food ingredient, animal health product, or emerging platform.
Host / platform CHO, HEK, E. coli, Bacillus, yeast, insect, anaerobe, viral producer cell, primary cell, iPSC, microbial consortium, or cell-free system.
Stage Discovery, feasibility, toxicology, preclinical, GMP clinical, commercial, tech transfer, redundant supply, or post-approval change.
Execution need Development, manufacturing, analytics, formulation, fill-finish, packaging, release, stability, regulatory support, logistics, or multi-site program coordination.
Quality level Research-grade, food-grade, ISO, GLP-adjacent, GMP-like, GMP clinical, commercial GMP, IVD, veterinary, or other controlled frameworks.
Geography UK & Ireland, Benelux, DACH, France, Iberia, Nordics, Central & Eastern Europe, or a multi-region European route.

Examples of routing logic.

CDMO Network Europe does not assume every program needs the same partner. The best path depends on technical reality.

AAV / viral vector

Route by vector system, plasmid supply, producer platform, titer, purification, analytics, GMP stage, fill-finish, and release testing.

LNP / RNA

Route by RNA type, encapsulation method, sterile format, particle analytics, potency, storage, clinical timeline, and DP requirements.

Microbial protein

Route by host, expression form, inclusion bodies vs soluble, fermentation scale, downstream complexity, endotoxin, and cost target.

Animal health

Route by species, regulatory route, biologic category, vaccine or mAb needs, batch scale, veterinary diagnostics, and market geography.

Need to map a complex program?

Connect With Us